The company is making a shift to focus on only the highest-value GenAI use cases and shut down pilots that were redundant or ...

Healthcare and medical technology company Johnson & Johnson (JNJ) has reported first-quarter financial results that beat Wall ...

Healthcare giant Johnson & Johnson (JNJ)is gearing up to release its first-quarter 2025 financials on April 15. JNJ stock has gained over ...

Analysts on Wall Street project that Johnson & Johnson (JNJ) will announce quarterly earnings of $2 per share in its forthcoming report, representing a decline of 12.7% year over year. Revenues ...

Mar Vista U.S. Quality Select Strategy stated the following regarding Johnson & Johnson (NYSE:JNJ) in its Q1 2025 investor ...

Analysts expect the New Brunswick, New Jersey-based company to report quarterly earnings at $2.58 per share, down from $2.71 ...

Johnson & Johnson Chief Executive Joaquin Duato said on Tuesday that tariffs on pharmaceuticals can create supply chain ...

Wall Street analysts expect Johnson & Johnson (JNJ) to post quarterly earnings of $2.57 per share in its upcoming report, which indicates a year-over-year decline of 5.2%. Revenues are expected to ...

Johnson & Johnson shares dipped slightly today on first-quarter results and an update on the impact of tariffs.